Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma × Proton Therapy × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 5 Prostatic Neoplasms 4 Brain Neoplasms 4 Pancreatic Neoplasms 3 Glioblastoma 3 Sarcoma 2 Neoplasms 2 Lung Neoplasms 2 Gliosarcoma 2 Glioma 2 Urothelial Carcinoma of the Bladder 1 Thoracic Neoplasms 1 Stage IA-IIA Breast Cancer 1 Rhabdomyosarcoma 1 Retinoblastoma 1 Resected Pancreatic Adenocarcinoma 1 Recurrence 1 Pinealoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Meningioma 1 Medulloblastoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Gastrointestinal Neoplasms 1 Eye Neoplasms 1 Esophageal Neoplasms 1 Ependymoma 1 Desmoplastic Small Round Cell Tumor 1 Chordoma 1 Chondrosarcoma 1

Interventions

Carboplatin 23 Cisplatin 19 pembrolizumab 13 Paclitaxel 12 Gemcitabine 12 Pemetrexed 11 130-nm albumin-bound paclitaxel 9 Everolimus 8 Cetuximab 8 Fluorouracil 7 Axitinib 6 osimertinib 5 durvalumab 5 Sunitinib 5 Radiotherapy 5 Erlotinib Hydrochloride 5 Docetaxel 5 Cyclophosphamide 5 Albumin-Bound Paclitaxel 5 Sorafenib 4 Radiation 4 Nivolumab 4 Ipilimumab 4 vosaroxin 3 Radiotherapy, Intensity-Modulated 3 Octreotide 3 Irinotecan 3 Bevacizumab 3 1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 3 pralsetinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡